Dr. Matthew Arthur Meissner, MD

Dr. Meissner practices at Geisinger Medical Center in Danville, Pennsylvania, part of Risant Health.

Dr. Meissner's NPI, 1174813786, was assigned on April 15, 2011. Dr. Meissner graduated from University of Texas Medical School at San Antonio in 2011. Dr. Meissner holds Texas license Q7423.

Dr. Meissner's primary practice is Geisinger Medical Center, at 100 North Academy Avenue, Danville, PA 17822 in Montour County. The practice phone is (570) 271-6211.

Dr. Meissner's primary practice is Geisinger Medical Center in Danville, Pennsylvania, part of Risant Health. Dr. Meissner is also affiliated with Geisinger Community Medical Center. The medical group on file is Geisinger. Dmand AI also links Dr. Meissner to 2 more hospitals and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Meissner practices, 4 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Meissner's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Meissner is licensed in Texas.

CMS data shows 559 Medicare services from Dr. Meissner across 13 procedure codes in 2024, for 337 Medicare patients. Medicare paid $33,085 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 337 Medicare patients who saw Dr. Meissner in 2024. The largest group is 65 to 74, with 175 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 12% are also on Medicaid. Their average risk score is 1.49, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Meissner's median patient age at 73, with 23% women.

In 2024, Dr. Meissner wrote 297 Medicare Part D claims for 104 patients. 96% of them were for generic drugs. CMS names the drug for 263 of them, across 6 drugs with 11 or more claims each, at $12,511 in total drug cost. In 2023, CMS named 182 claims across 5 drugs.

Dr. Meissner accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Meissner as offering telehealth.

Prostate resection: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 13 papers to Dr. Meissner, published from 2014 to 2024. 2014 was the busiest year, with 2. The most frequent topics are Carcinoma, Transitional Cell. Dr. Meissner has published most often in Urol Case Rep. Dr. Meissner's most frequent co-authors are Marisa Meyer Clifton, MD, Tullika Garg, MD and Bishoy A. Gayed, MD.

Dmand AI links Dr. Meissner to 1 clinical trial. 1 is still active or recruiting. Conditions studied include Urinary Bladder Neoplasms and Urinary Bladder Diseases.

CMS Open Payments shows 27 general payments to Dr. Meissner from 15 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 96% of the total. Boston Scientific Corporation paid the most, $298.

Dr. Meissner graduated from University of Texas Medical School at San Antonio in 2011.